163 related articles for article (PubMed ID: 11903277)
21. Pseudotumour cerebri as a manageable side effect of prolonged all-trans retinoic acid therapy in an adult patient with acute promyelocytic leukaemia.
Gallipoli P; Drummond MW
Eur J Haematol; 2009 Mar; 82(3):242-3. PubMed ID: 19018859
[No Abstract] [Full Text] [Related]
22. Occurrence of cerebellar thrombohemorrhage during all-trans retinoic acid (ATRA) therapy in a case of acute promyelocytic leukemia.
Parma M; Casaroli I; Pogliani EM
Haematologica; 1996; 81(4):379-80. PubMed ID: 8870387
[No Abstract] [Full Text] [Related]
23. Strategies for the treatment of acute promyelocytic leukemia.
Frankfurt O; Tallman MS
J Natl Compr Canc Netw; 2006 Jan; 4(1):37-50. PubMed ID: 16403403
[TBL] [Abstract][Full Text] [Related]
24. Brief report: severe symptoms of hyperhistaminemia after the treatment of acute promyelocytic leukemia with tretinoin (all-trans-retinoic acid).
Koike T; Tatewaki W; Aoki A; Yoshimoto H; Yagisawa K; Hashimoto S; Furukawa T; Saitoh H; Takahashi M; Yang LB
N Engl J Med; 1992 Aug; 327(6):385-7. PubMed ID: 1625712
[No Abstract] [Full Text] [Related]
25. 4-oxo retinoic acid for refractory acute promyelocytic leukemia in children with all-trans retinoic acid therapy.
Takitani K; Tamai H; Morinobu T; Kawamura N; Miyake M; Fujimoto T; Mino M
J Nutr Sci Vitaminol (Tokyo); 1995 Aug; 41(4):493-8. PubMed ID: 8676222
[TBL] [Abstract][Full Text] [Related]
26. All-trans retinoic acid-induced vasculitis and hemonecrosis of the ileum in a patient with acute promyelocytic leukemia.
Yamada K; Sugimoto K; Matsumoto T; Narumi K; Oshimi K
Leukemia; 1999 Apr; 13(4):647-8. PubMed ID: 10214877
[No Abstract] [Full Text] [Related]
27. Complications of therapy in cancer patients: Case 2. Scrotal ulceration during all-trans-retinoic acid therapy for acute promyelocytic leukemia.
Gettinger S; Shapira I; Scheinfeld N; Grossbard M
J Clin Oncol; 2004 Nov; 22(22):4648-9. PubMed ID: 15542816
[No Abstract] [Full Text] [Related]
28. Hypercalcemia due to all-trans retinoic acid therapy for acute promyelocytic leukemia: a case report of effective treatment with bisphosphonate.
Sakamoto O; Yoshinari M; Rikiishi T; Fujiwara I; Imaizumi M; Tsuchiya S; Iinuma K
Pediatr Int; 2001 Dec; 43(6):688-90. PubMed ID: 11737750
[No Abstract] [Full Text] [Related]
29. Newly diagnosed acute promyelocytic leukemia: arsenic moves front and center.
Estey EH; Hutchinson F
J Clin Oncol; 2011 Jul; 29(20):2743-6. PubMed ID: 21646610
[No Abstract] [Full Text] [Related]
30. [Treatment of malignant hemopathies with all transretinoic acid].
Fenaux P; Chomienne C
Presse Med; 1997 Oct; 26(29):1399-405. PubMed ID: 9404351
[No Abstract] [Full Text] [Related]
31. Fatal thromboembolism in acute promyelocytic leukaemia treated with a combination of all-trans retinoic acid and aprotonin.
Mahendra P; Keeling DM; Hood IM; Baglin TP; Marcus RE
Clin Lab Haematol; 1996 Mar; 18(1):51-2. PubMed ID: 9118606
[TBL] [Abstract][Full Text] [Related]
32. Retinoid differentiation therapy in promyelocytic leukemia.
Chomienne C; Fenaux P; Degos L
FASEB J; 1996 Jul; 10(9):1025-30. PubMed ID: 8801163
[TBL] [Abstract][Full Text] [Related]
33. Use of all-trans retinoic acid to treat acute promyelocytic leukemia: a case with very severe features at the onset in Nicaragua.
Flores A; Malta A; Pacheco C; Baez F; Ocampo E; Conter V; Masera G; Biondi A; Rovelli A
Med Pediatr Oncol; 1996 Apr; 26(4):258-60. PubMed ID: 8600338
[TBL] [Abstract][Full Text] [Related]
34. All-trans-retinoic acid-induced myositis in a child with acute promyelocytic leukemia.
Citak FE; Ezer U; Akkaya E; Ozbulbul N; Bahce M; Kurekci AE
Haematologica; 2006 Aug; 91(8 Suppl):ECR35. PubMed ID: 16923519
[TBL] [Abstract][Full Text] [Related]
35. Bilateral osteonecrosis of the head of the femur during treatment with retinoic acid in a young patient with acute promyelocytic leukemia.
Sakakura M; Nishii K; Usui E; Monma F; Tsukada T; Shiku H
Int J Hematol; 2006 Apr; 83(3):252-3. PubMed ID: 16720557
[TBL] [Abstract][Full Text] [Related]
36. Hypercalcemia due to an interaction of all-trans retinoic acid (ATRA) and itraconazole therapy for acute promyelocytic leukemia successfully treated with zoledronic acid.
Cordoba R; Ramirez E; Lei SH; Lopez de la Guia A; Sanjurjo MJ; Carcas AJ; Hernandez-Navarro F
Eur J Clin Pharmacol; 2008 Oct; 64(10):1031-2. PubMed ID: 18584165
[No Abstract] [Full Text] [Related]
37. [Arsenic efficient in acute promyelocytic leukemia].
Lehmann S; Paul C
Lakartidningen; 1999 Dec; 96(50):5626-8. PubMed ID: 10643228
[TBL] [Abstract][Full Text] [Related]
38. Reversible cardiac dysfunction without myocytolysis related to all-trans retinoic acid administration during induction therapy of acute promyelocytic leukemia.
Manna A; Cadenotti L; Motto A; Ballo P
Ann Hematol; 2009 Jan; 88(1):91-2. PubMed ID: 18633613
[No Abstract] [Full Text] [Related]
39. Clinical and molecular aspects of retinoid therapy for acute promyelocytic leukemia.
Warrell RP
Int J Cancer; 1997 Feb; 70(4):496-7. PubMed ID: 9033666
[TBL] [Abstract][Full Text] [Related]
40. Expression of retinoic acid receptor-target genes during retinoic acid therapy for acute promyelocytic leukemia.
Takitani K; Koh M; Zhu CL; Inoue A; Kuno T; Tanoue H; Miyake M; Nakagawa T; Tamai H
Leukemia; 2003 Mar; 17(3):646-8. PubMed ID: 12646960
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
